Unified Patent Court (UPC) analytics are now available. Check here

In the competitive field of Drug Additives, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Drug Additives technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the Drug Additives Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Drug Additives industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Drug Additives industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Drug Additives industry

EP4005555Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 17, 2025HAMM&WITTKOPP PATENTANWALTE PARTMBB
EP4005555Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 14, 2025ELKINGTON AND FIFE
EP3917503Methods Of Preparing Lipid NanoparticlesMODERNATXFeb 6, 2025BIONTECH
EP3411476Enhanced Production Of ImmunoglobulinsTRIANNIJan 24, 2025REGENERON PHARMACEUTICALS
EP4056176Methods Of Reducing The Risk Of Cardiovascular Events In A SubjectAMARIN PHARMACEUTICALS IRELANDJan 24, 2025ELKINGTON AND FIFE
EP2662094Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB
EP3090730Novel Pharmaceutical CompositionNOVARTISJan 10, 2025ZENTIVA KS
EP3494961Compositions And Methods For Treating Chronic Inflammation And Inflammatory DiseasesINFIRST HEALTHCAREJan 10, 2025HAMM&WITTKOPP PATENTANWALTE PARTMBB
EP2662094Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 9, 2025FRESENIUS KABI DEUTSCHLAND
EP3090730Novel Pharmaceutical CompositionNOVARTISJan 9, 2025GALENICUM HEALTH SLU

To stay ahead in the competitive Drug Additives industry, companies are constantly innovating. Here are the top patents facing oppositions in the Drug Additives industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3474820Feb 7, 2024Glp-1 Compositions And Uses ThereofNOVO NORDISK8
EP3263106Oct 25, 2023Method For Suppressing Bitterness Of Quinoline DerivativeEISAI R&D MANAGEMENT8
EP3103448Jul 3, 2019Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTIS7
EP3283059Jan 3, 2024Method For Producing Rna CompositionsCUREVAC MANUFACTURING7
EP3810201Aug 2, 2023Gip/Glp1 Agonist CompositionsELI LILLY7
EP3090730Jul 3, 2024Novel Pharmaceutical CompositionNOVARTIS7
EP2598118Sep 5, 2018Preservative Free Bimatoprost And Timolol SolutionsALLERGAN6
EP2662094Apr 17, 2024Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICS6
EP3302565Nov 6, 2019Solid Dosage Forms Of PalbociclibPFIZER6
EP2345410Dec 30, 2020Controlled Release Pharmaceutical CompositionASTELLAS PHARMA6